2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells by Xiaomeng Xie, Xueyin Zu, Kyle Laster, Zigang Dong, Dong Joon Kim

Connect to this object online.

Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma by Zhenzhen Li, Zhenzhen Li, Xin Li, Xinyu He, Xinyu He, Xuechao Jia, Xuechao Jia, Xiaofan Zhang, Xiaofan Zhang, Bingbing Lu, Bingbing Lu, Jimin Zhao, Jimin Zhao, Jimin Zhao, Jing Lu, Jing Lu, Jing Lu, Lexia Chen, Lexia Chen, Ziming Dong, Ziming Dong, Ziming Dong, Ziming Dong, Kangdong Liu, Kangdong Liu, Kangdong Liu, Kangdong Liu, Kangdong Liu, Zigang Dong, Zigang Dong, Zigang Dong, Zigang Dong

Connect to this object online.

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity by Xiaojie Chen, Xiaojie Chen, Xiaojie Chen, Long-Fei Mao, Long-Fei Mao, Long-Fei Mao, Siqi Tian, Xueli Tian, Xueqiong Meng, Mu-Kuo Wang, Weifeng Xu, Yue-Ming Li, Kangdong Liu, Kangdong Liu, Zigang Dong, Zigang Dong

Connect to this object online.

Ribonucleotide reductase small subunit M2 promotes the proliferation of esophageal squamous cell carcinoma cells via HuR-mediated mRNA stabilization by Jing Zhang, Qiong Wu, Yifei Xie, Feng Li, Huifang Wei, Yanan Jiang, Yan Qiao, Yinhua Li, Yanan Sun, Han Huang, Mengmeng Ge, Dengyun Zhao, Zigang Dong, Kangdong Liu

Connect to this object online.

Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo by Fanxiang Yin, Ran Zhao, Dhilli Rao Gorja, Xiaorong Fu, Ning Lu, Hai Huang, Beibei Xu, Hanyong Chen, Jung-Hyun Shim, Kangdong Liu, Zhi Li, Kyle Vaughn Laster, Zigang Dong, Mee-Hyun Lee

Connect to this object online.